Alberta Investment Management Corp acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 44,600 shares of the company's stock, valued at approximately $10,595,000.
Other large investors have also recently made changes to their positions in the company. Integrated Wealth Concepts LLC lifted its position in shares of Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock worth $601,000 after buying an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in Cardinal Health in the 2nd quarter worth approximately $1,935,000. Cerity Partners LLC increased its stake in Cardinal Health by 17.0% in the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock worth $6,792,000 after acquiring an additional 5,880 shares during the last quarter. Finally, Nebula Research & Development LLC raised its holdings in shares of Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock worth $1,736,000 after acquiring an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. Wells Fargo & Company raised their target price on shares of Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. Zacks Research downgraded shares of Cardinal Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, June 12th. Bank of America increased their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a "buy" rating in a research report on Thursday, July 2nd. Citigroup lifted their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, August 12th. Finally, Barclays boosted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a report on Thursday. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $265.93.
Read Our Latest Research Report on Cardinal Health
Cardinal Health Stock Performance
NYSE:CAH opened at $234.92 on Monday. The firm has a market capitalization of $54.64 billion, a PE ratio of 32.49, a PEG ratio of 1.26 and a beta of 0.49. The stock's fifty day moving average is $230.30 and its 200 day moving average is $217.19. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. During the same period in the previous year, the firm earned $2.08 earnings per share. Cardinal Health's quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current year.
Cardinal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.
Cardinal Health Profile
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
